Table 3.
Cases, percentages of discordant and clinically significant cases across the subspecialty teams studied
| Subspecialty | Number of cases (percentage of total) | Concordance (%) | Discordant cases (percentage of subspecialty) | Clinically significant discordance (percentage of subspecialty) |
|---|---|---|---|---|
| Skin | 1356 (45.2) | 1298 (95) | 98 (7.2) | 38 (2.8) |
| Gastrointestinal tract | 830 (27.7) | 774 (93.2) | 56 (6.8) | 26 (3.1) |
| Gynaecology | 463 (15.4) | 397 (85.7) | 66 (14.3) | 15 (3.2) |
| Urology | 140 (4.7) | 110 (78.5) | 30 (21.4) | 7 (5.0) |
| Head and neck | 85 (2.8) | 82 (97.6) | 2 (2.4) | 0 (0.0) |
| Soft tissues | 67 (2.2) | 66 (98.5) | 1 (1.5) | 0 (0.0) |
| Breast | 47 (1.6) | 45 (95.7) | 2 (4.3) | 0 (0.0) |
| Other general | 13 (0.4) | 12 (92.3) | 1 (9.1) | 0 (0.0) |